CLEVELAND, May 25 /PRNewswire/ -- Demand for nanotechnology health care
products in the US is projected to increase nearly 50 percent per year to
$6.5 billion in 2009. Gains will be led by the introduction of new, improved
cancer and central nervous system therapies based on solubilization
technologies. Diagnostic tests based on nanoarrays and quantum dots, and
imaging agents based on superparamagnetic iron oxide nanoparticles will also
see strong growth. In spite of progress in introducing new products, the vast
potential of nanotechnology in the health care field will not be fully
realized for at least a decade as stringent regulatory barriers and technical
complexities delay the commercialization of targeted drug delivery systems,
tissue regenerators and other breakthrough products. However, by 2020, demand
for nanotechnology health care products is projected to exceed $100 billion.
These and other trends are presented in Nanotechnology in Health Care, a new
study from The Freedonia Group, Inc., a Cleveland-based market research firm.
The need for new or improved medicines in several therapeutic areas will
lead to the increasing use of nanotechnology in pharmaceutical applications.
Protein- and peptide-based compounds for cancer, diabetes, infectious diseases
and organ transplant acceptance will account for most growth. Over the long
term, pharmaceutical applications for nanotechnology will extend into most
therapeutic classes and encompass all types of formulations and delivery
Advances in nanotechnology are also creating a wealth of opportunities for
the development of new, improved medical diagnostic products and techniques.
Nanoparticle formulations of superparamagnetic iron oxide, gadolinium,
perfluorocarbon and specialty polymers will broaden in vivo imaging
capabilities by enabling the detection of tumors, plaque, genetic defects and
other disease states at much earlier stages and with lower, safer
concentrations of contrast agents. Several medical supplies and devices will
emerge as key applications for nanotechnology.
Nanomaterials are already gaining significant demand as active ingredients
of burn and wound dressings. In the long term, advances in nanotechnology are
expected to lead to the introduction of new, improved medical supply and
device coatings as well as a new, diverse group of medical implants. The
greatest short-term impact of nanotechnology in health care will be in
therapies and diagnostics for cancer and central nervous system disorders.
Contact: Corinne Gangloff, email@example.com, 440-684-9600
SOURCE The Freedonia Group, Inc.